Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modeling study in the Canadian Medical Association ...
Sep 9, 2024
0
2
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection ...
Sep 5, 2024
0
2
Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Sep 5, 2024
0
0
Cases of the mpox virus have killed two people in Cameroon since April with six further and 40 other suspected cases, the health ministry said Wednesday.
10 hours ago
0
0
While COVID-19 continues to evolve, there is some good news when it comes to detecting the virus.
Sep 9, 2024
0
0
